SCHEMBL23728940

SCHEMBL23728940

CCOC(=O)c1nc(C(N)CCNC(=O)c2cc(Nc3nc(C(N)CCNC(=NC(=O)OC(C)(C)C)NC(=O)OC(C)(C)C)cn3C)cn2C)cn1C

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
P2RY12 Q9H244 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23728968 0.92
SCHEMBL23728934 0.92 KDM4E (0.33) P2RY12
SCHEMBL23728958 0.92 KDM4E (0.33) P2RY12
SCHEMBL23728897 0.89 RPS6KA3 (0.33) P2RY12
SCHEMBL28984129 0.83 HDAC1 (0.40) P2RY12
SCHEMBL23728949 0.82 MEN1 (0.33)
SCHEMBL23728911 0.82 MEN1 (0.33)
SCHEMBL23728952 0.81 P2RX3 (0.35)
SCHEMBL23728900 0.80 MC4R (0.35)
SCHEMBL23728922 0.80 HDAC1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4100404-A1 METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE Design Therapeutics, Inc. (US) 2022-12-14 EP disclosed
WO-2021158707-A1 METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE Design Therapeutics, Inc. (US) 2021-08-12 WO disclosed